{"id":60882,"date":"2024-02-28T07:13:05","date_gmt":"2024-02-28T07:13:05","guid":{"rendered":"https:\/\/medsname.com\/dytor\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"dytor","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/dytor\/","title":{"rendered":"Dytor"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Dytor?<\/h3>\n<p style=\"margin:0;\"><strong>Dytor<\/strong> este un <strong>5 \/ 10 \/ 20 mg comprimat de torasemid\u0103<\/strong> de la Cipla \u2014 un <strong>diuretic de ans\u0103 (structur\u0103 piridin-sulfonilureic)<\/strong> care ac\u021bioneaz\u0103 asupra <strong>NKCC2 (cotransportor Na-K-2Cl) \u00een por\u021biunea groas\u0103 ascendent\u0103<\/strong>. Torasemida (torsemid\u0103 \u00een nomenclatura SUA) a fost introdus\u0103 de Boehringer Mannheim \u00een 1993 \u2014 al treilea diuretic de ans\u0103 major dup\u0103 furosemid\u0103 \u0219i bumetanid\u0103. Promovat\u0103 datorit\u0103 biodisponibilit\u0103\u021bii predictibile \u0219i duratei mai lungi comparativ cu furosemida. Timp de \u00eenjum\u0103t\u0103\u021bire 3-4 ore (mai lung dec\u00e2t la furosemid\u0103); debut 30-60 minute; efect maxim 1-2 ore; durat\u0103 6-8 ore. Indica\u021bie principal\u0103: <strong>edem \u00een insuficien\u021b\u0103 cardiac\u0103 cronic\u0103, hipertensiune (inclusiv refractar\u0103), ascit\u0103 hepatic\u0103, edem \u00een boala renal\u0103 cronic\u0103<\/strong>. Dozaj tipic: <strong>Hipertensiune arterial\u0103:<\/strong> 5-10 mg o dat\u0103 pe zi diminea\u021ba. Torasemida este <strong>singurul diuretic de ans\u0103 cu dovezi rezonabile antihipertensive<\/strong> \u2014 durata sa mai lung\u0103 de ac\u021biune \u0219i activitatea suplimentar\u0103 anti-aldosteron\/anti-fibrotic\u0103 \u00eel fac mai potrivit pentru controlul tensiunii arteriale o dat\u0103 pe zi dec\u00e2t furosemida. Contraindica\u021bii cheie: vede\u021bi lista complet\u0103 mai jos. Monitoriza\u021bi electroli\u021bii, creatinina \u0219i glicemia. <strong>Nu combina\u021bi cu litiu<\/strong> (diureticele tiazidice\/de ans\u0103 pot precipita toxicitatea litiului). <strong>Utilizarea \u00een sarcin\u0103 este specific\u0103 cazului<\/strong> (consulta\u021bi nota despre sarcin\u0103). Pentru majoritatea pacien\u021bilor hipertensivi, diureticele func\u021bioneaz\u0103 cel mai bine ca <strong>al doilea sau al treilea agent<\/strong> \u2014 de obicei combinat cu un BRA, inhibitor ACE sau blocant al canalelor de calciu, mai degrab\u0103 dec\u00e2t utilizat singur.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Dytor?<\/h2>\n<p>Dytor este un comprimat oral de torasemid\u0103 5\/10\/20 mg de la Cipla, furnizat \u00een cutii de 30-180 comprimate. Torasemida (torsemid\u0103 \u00een nomenclatura SUA) a fost introdus\u0103 de Boehringer Mannheim \u00een 1993 \u2014 al treilea mare diuretic de ans\u0103 dup\u0103 furosemid\u0103 \u0219i bumetanid\u0103. Comercializat datorit\u0103 biodisponibilit\u0103\u021bii predictibile \u0219i duratei mai lungi de ac\u021biune comparativ cu furosemida.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Torasemida<\/h2>\n<p>Torasemida inhib\u0103 <strong>NKCC2 (cotransportor Na-K-2Cl) \u00een por\u021biunea groas\u0103 ascendent\u0103<\/strong>. Efectele secundare:<\/p>\n<ul>\n<li><strong>Reducere dramatic\u0103 a reabsorb\u021biei de sodiu<\/strong> \u2014 diureticele de tip loop blocheaz\u0103 cel mai mare segment de reabsorb\u021bie a sodiului din nefron; p\u00e2n\u0103 la 25% din sodiul filtrat poate fi excretat<\/li>\n<li><strong>Diurez\u0103 intens\u0103<\/strong> \u00een 1-2 ore de la administrarea oral\u0103 (5 minute IV) \u2014 util\u0103 \u00een insuficien\u021ba cardiac\u0103 acut\u0103 decompensat\u0103 \u0219i edemul pulmonar<\/li>\n<li><strong>Pierdere de magneziu \u0219i calciu<\/strong> pe l\u00e2ng\u0103 sodiu \u0219i potasiu \u2014 \u00een contrast cu tiazidele care re\u021bin calciul<\/li>\n<li><strong>Vasodilata\u021bie venoas\u0103 direct\u0103<\/strong> \u00een c\u00e2teva minute de la administrarea IV \u2014 contribuie la ameliorarea simptomelor \u00een edemul pulmonar acut \u00eenainte de apari\u021bia diurezei<\/li>\n<li><strong>Activeaz\u0103 sinteza prostaglandinelor<\/strong> \u00een rinichi \u2014 fundamentul interac\u021biunii cu AINS (AINS atenueaz\u0103 efectul diureticelor de tip loop)<\/li>\n<li><strong>Antagonism slab al receptorilor mineralocorticoizi<\/strong> \u2014 reduce hipokalemia \u0219i ofer\u0103 activitate anti-fibrotic\u0103 par\u021bial\u0103 pe miocard<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate \u0219i bazate pe dovezi<\/h2>\n<ul>\n<li><strong>Edem \u00een insuficien\u021b\u0103 cardiac\u0103 cronic\u0103, hipertensiune (inclusiv refractar\u0103), ascit\u0103 hepatic\u0103, edem \u00een boala renal\u0103 cronic\u0103<\/strong> \u2014 indica\u021bie principal\u0103<\/li>\n<li><strong>Insuficien\u021b\u0103 cardiac\u0103 cronic\u0103 cu edem<\/strong><\/li>\n<li><strong>Ascit\u0103 cirotic\u0103<\/strong> (combinat cu spironolacton\u0103)<\/li>\n<li><strong>Hipertensiune, inclusiv hipertensiune refractar\u0103<\/strong> (singurul diuretic de ans\u0103 cu dovezi rezonabile \u00een hipertensiune)<\/li>\n<li><strong>Edem asociat BCR<\/strong> \u2014 eficient la FG &lt;30 unde tiazidele e\u0219ueaz\u0103<\/li>\n<li><strong>Rezisten\u021b\u0103 la furosemid\u0103<\/strong> \u2014 trecerea la torasemid\u0103 readuce adesea r\u0103spunsul datorit\u0103 biodisponibilit\u0103\u021bii mai bune<\/li>\n<\/ul>\n<p><strong>Dovezile din studiile pivotale:<\/strong> <strong>Studiul TORIC (2002)<\/strong> \u2014 studiu observa\u021bional pe 1.377 de pacien\u021bi cu insuficien\u021b\u0103 cardiac\u0103; torasemid\u0103 vs furosemid\u0103, grupul cu torasemid\u0103 a prezentat o mortalitate cu 52% mai mic\u0103. Foarte citat, dar criticat pentru designul nerandomizat. <strong>TRANSFORM-HF (2023)<\/strong> \u2014 studiu randomizat amplu pe 2.859 de pacien\u021bi cu insuficien\u021b\u0103 cardiac\u0103, torasemid\u0103 vs furosemid\u0103; <strong>nicio diferen\u021b\u0103 semnificativ\u0103<\/strong> \u00een mortalitatea din toate cauzele la 12 luni. Concluzia actual\u0103: torasemida este cel pu\u021bin la fel de bun\u0103 ca furosemida; alegerea se bazeaz\u0103 pe biodisponibilitate, comoditate \u0219i tolerabilitate, nu pe mortalitate.<\/p>\n<h2 class=\"wp-block-heading\">Doza Dytor<\/h2>\n<p><strong>Doza cronic\u0103:<\/strong> <strong>Hipertensiune arterial\u0103:<\/strong> 5-10 mg o dat\u0103 pe zi diminea\u021ba. Torasemida este <strong>singurul diuretic de ans\u0103 cu dovezi rezonabile antihipertensive<\/strong> \u2014 durata mai lung\u0103 de ac\u021biune \u0219i activitatea anti-aldosteron\/anti-fibrotic\u0103 suplimentar\u0103 o fac mai potrivit\u0103 pentru controlul tensiunii arteriale o dat\u0103 pe zi dec\u00e2t furosemida.<\/p>\n<p><strong>Alte indica\u021bii:<\/strong> <strong>Insuficien\u021b\u0103 cardiac\u0103:<\/strong> 10-20 mg pe zi oral ini\u021bial; ajusta\u021bi la 10-100 mg\/zi. Administrarea o dat\u0103 pe zi este de obicei suficient\u0103. <strong>Ascit\u0103 cirotic\u0103:<\/strong> 5-40 mg\/zi \u00een combina\u021bie cu spironolacton\u0103 100-200 mg\/zi. <strong>Edem \u00een BCR:<\/strong> doze mai mari necesare (20-100 mg\/zi) pe m\u0103sur\u0103 ce nefronii scad.<\/p>\n<p><strong>Administrare:<\/strong> o dat\u0103 pe zi (sau de dou\u0103 ori pe zi pentru doze mari de diuretice de ans\u0103 \u00een insuficien\u021b\u0103 cardiac\u0103), diminea\u021ba. Administrarea seara provoac\u0103 nicturie \u0219i ar trebui evitat\u0103 c\u00e2nd este posibil. Lua\u021bi la aceea\u0219i or\u0103 \u00een fiecare zi. Alimenta\u021bia nu afecteaz\u0103 semnificativ absorb\u021bia pentru niciunul dintre aceste diuretice.<\/p>\n<p><strong>Program de monitorizare:<\/strong><\/p>\n<ul>\n<li><strong>Valori ini\u021biale:<\/strong> uree, electroli\u021bi (\u00een special potasiu \u0219i sodiu), creatinin\u0103, eGFR, glucoz\u0103, acid uric seric. Tensiunea arterial\u0103 acas\u0103 sau \u00een clinic\u0103 \u0219i greutatea zilnic\u0103 pentru pacien\u021bii cu insuficien\u021b\u0103 cardiac\u0103.<\/li>\n<li><strong>la 1-2 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea sau modificarea dozei:<\/strong> repetarea electroli\u021bilor \u0219i a creatininei. A\u0219tepta\u021bi modific\u0103ri minore ale electroli\u021bilor; investiga\u021bi modific\u0103ri substan\u021biale.<\/li>\n<li><strong>4-6 s\u0103pt\u0103m\u00e2ni:<\/strong> evaluarea tensiunii arteriale \u0219i panelul metabolic complet.<\/li>\n<li><strong>Continuu:<\/strong> electroli\u021bi anuali, acid uric, glucoz\u0103 \u0219i panel lipidic odat\u0103 stabilizat. Mai frecvent \u00een insuficien\u021b\u0103 renal\u0103 cronic\u0103, insuficien\u021b\u0103 cardiac\u0103 sau la terapie combinat\u0103.<\/li>\n<li><strong>\u00centrerupe\u021bi sau reduce\u021bi doza la:<\/strong> sodiu &lt;130 cu simptome, potasiu 5,5, cre\u0219tere creatinin\u0103 &gt;30%, gut\u0103 nou\u0103, simptome severe de deshidratare.<\/li>\n<\/ul>\n<p><strong>\u00centrerupere:<\/strong> nu exist\u0103 sindrom de sevraj, dar \u00eentreruperea brusc\u0103 poate provoca reten\u021bie de volum de tip rebound la pacien\u021bii cu IC sub doze cronice mari de diuretice de ans\u0103 \u2014 reduce\u021bi progresiv doza acolo unde este posibil \u0219i monitoriza\u021bi greutatea.<\/p>\n<ul>\n<li><strong>Biodisponibilitate 80-100%<\/strong> (furosemid\u0103 10-90%) \u2014 util\u0103 \u00een special la pacien\u021bii cu insuficien\u021b\u0103 cardiac\u0103 congestiv\u0103, edem intestinal sau r\u0103spuns inconsistent la furosemid\u0103.<\/li>\n<li><strong>Antagonism slab al aldosteronului<\/strong> \u2014 activitate antifibrotic\u0103 par\u021bial\u0103 \u00een miocard. Semnifica\u021bia clinic\u0103 modest\u0103; probabil contribuie la beneficiile observate \u00een studiul TORIC.<\/li>\n<li><strong>Mai pu\u021bin hipokaliemiant<\/strong> dec\u00e2t furosemida la doze natriuretice echivalente (legat de efectul antagonist al aldosteronului).<\/li>\n<li><strong>Echivalen\u021b\u0103 de dozaj:<\/strong> torasemid\u0103 10 mg \u2248 furosemid\u0103 40 mg. Util la schimbarea \u00eentre agen\u021bi.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;1%):<\/strong><\/p>\n<ul>\n<li><strong>Hipokaliemie<\/strong> (mai pu\u021bin dec\u00e2t furosemida)<\/li>\n<li><strong>Hipomagnezemie<\/strong><\/li>\n<li><strong>Hiponatremie<\/strong><\/li>\n<li><strong>AKI pre-renal\u0103<\/strong> \u00een cazul supra-diurezei<\/li>\n<li><strong>Ototoxicitate<\/strong> (rar; mai pu\u021bin frecvent dec\u00e2t furosemida pe unitate de natriurez\u0103)<\/li>\n<li><strong>Hiperuricemie<\/strong><\/li>\n<li><strong>Hiperglicemie u\u0219oar\u0103<\/strong><\/li>\n<li><strong>Hipotenziune postural\u0103<\/strong><\/li>\n<li><strong>Ame\u021beli, cefalee<\/strong><\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar clinic importante:<\/strong><\/p>\n<ul>\n<li><strong>Hiponatremie sever\u0103<\/strong> \u2014 \u00een special la persoanele \u00een v\u00e2rst\u0103 cu diete s\u0103race \u00een sare, st\u0103ri predispuse la SIADH sau \u00een combina\u021bie cu SSRI. Se poate manifesta prin confuzie, c\u0103deri sau convulsii.<\/li>\n<li><strong>Pancreatit\u0103<\/strong> \u2014 efect rar al clasei de tiazide\/loop; \u00eentrerupe\u021bi imediat la apari\u021bia durerii abdominale superioare cu cre\u0219tere a lipazei<\/li>\n<li><strong>Trombocitopenie, leucopenie, agranulocitoz\u0103<\/strong> \u2014 reac\u021bii rare de hipersensibilitate (mai frecvente la tiazide dec\u00e2t la diureticele de ans\u0103)<\/li>\n<li><strong>Miopie acut\u0103 \u0219i glaucom cu unghi \u00eenchis<\/strong> \u2014 reac\u021bie rar\u0103 din clasa sulfonamidelor, care apare \u00een c\u00e2teva ore sau zile de la \u00eenceperea tratamentului; \u00eentrerupe\u021bi imediat dac\u0103 apar dureri oculare sau modific\u0103ri ale vederii<\/li>\n<li><strong>Sindromul Stevens-Johnson \/ necroliz\u0103 epidermic\u0103 toxic\u0103<\/strong> \u2014 extrem de rar, dar raportat<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Anurie<\/li>\n<li>Hipersensibilitate la sulfonamide<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 cu com\u0103 hepatic\u0103<\/li>\n<li>Hiponatremie sever\u0103 sau hipokaliemie la evaluarea ini\u021bial\u0103<\/li>\n<li>Deshidratare sever\u0103 \u0219i azotemie prerenal\u0103<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> evitate pentru hipertensiunea arterial\u0103 obi\u0219nuit\u0103; utilizate doar pentru indica\u021bii clare (edem pulmonar, insuficien\u021b\u0103 cardiac\u0103 rezistent\u0103) sub \u00eendrumare specializat\u0103. Diureticele de tip bucl\u0103 trec placenta \u0219i pot reduce produc\u021bia de urin\u0103 fetal\u0103.<\/p>\n<p><strong>Al\u0103ptarea:<\/strong> \u00een general acceptabile la doze mici; dozele mari pot suprima lacta\u021bia (\u00een special tiazidele). Antihipertensive alternative (propranolol, nifedipin\u0103) sunt preferate atunci c\u00e2nd este posibil.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Litiu \u2014 INTERAC\u021aIUNE CRITIC\u0102.<\/strong> Diureticele tiazidice \u0219i cele de ans\u0103 reduc clearance-ul renal al litiului \u0219i pot precipita toxicitatea acestuia. Evita\u021bi combina\u021bia dac\u0103 este posibil; dac\u0103 este inevitabil, monitoriza\u021bi nivelurile de litiu s\u0103pt\u0103m\u00e2nal \u00een prima lun\u0103 \u0219i reduce\u021bi doza de litiu cu 25-50%.<\/li>\n<li><strong>AINS<\/strong> \u2014 reduc efectul diuretic (prin blocarea prostaglandinelor) \u0219i cresc substan\u021bial riscul de insuficien\u021b\u0103 renal\u0103 acut\u0103 atunci c\u00e2nd sunt combinate cu ACEi\/ARB (\u201ctripla lovitur\u0103\u201d). Utiliza\u021bi paracetamol preferen\u021bial pentru durerea cronic\u0103.<\/li>\n<li><strong>Inhibitori ACE \u0219i ARB<\/strong> \u2014 combina\u021bia este standard \u0219i benefic\u0103 \u00een HTA; ad\u0103ugarea de ACEi\/ARB blocheaz\u0103 activarea compensatorie a sistemului RAAS \u0219i poten\u021beaz\u0103 efectul diuretic. Monitoriza\u021bi potasiul \u0219i creatinina.<\/li>\n<li><strong>Suplimente de potasiu \u0219i diuretice economisitoare de potasiu<\/strong> \u2014 adesea necesare pentru a compensa hipokaliemia indus\u0103 de diureticele de tip loop\/tiazidic. Monitoriza\u021bi potasiul; evita\u021bi corec\u021bia excesiv\u0103.<\/li>\n<li><strong>Digoxin\u0103<\/strong> \u2014 hipokaliemia poten\u021beaz\u0103 toxicitatea digoxinului (diureticele loop \u0219i tiazidice); spironolactona reduce direct clearance-ul digoxinului. Monitoriza\u021bi nivelurile de digoxin \u0219i potasiu la \u00eenceperea sau modificarea diureticului.<\/li>\n<li><strong>Corticoesteroide orale, amfotericina B, laxative stimulante<\/strong> \u2014 hipokaliemie aditiv\u0103 (diuretice loop\/tiazidice) sau necesitate mascat\u0103 de potasiu (spironolacton\u0103).<\/li>\n<li><strong>Antidiabetice orale, insulin\u0103<\/strong> \u2014 diureticele tiazidice \u0219i (\u00een mai mic\u0103 m\u0103sur\u0103) cele loop \u00eenr\u0103ut\u0103\u021besc toleran\u021ba la glucoz\u0103; poate fi necesar\u0103 ajustarea dozei.<\/li>\n<li><strong>Colestiramin\u0103 \/ colestipol<\/strong> \u2014 reduce absorb\u021bia tiazidelor \u0219i a diureticelor de ans\u0103 cu 40-85%. Administrarea trebuie separat\u0103 cu 4 ore.<\/li>\n<li><strong>Antibiotice aminoglicozidice (gentamicin\u0103, amikacin\u0103)<\/strong> \u2014 ototoxicitate aditiv\u0103. Evita\u021bi utilizarea concomitent\u0103 la doze IV mari.<\/li>\n<li><strong>Alcool<\/strong> \u2014 hipotensiune postural\u0103 aditiv\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Pozi\u021bia lui Dytor \u00een clasa diureticelor<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Clas\u0103<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Reprezentan\u021bi<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Utilizare tipic\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tiazid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">HCTZ<\/a>, clortalidon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HTN prim-line, pietre de calciu, DI nefrogen<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Asem\u0103n\u0103tor tiazidelor<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/natrilix-sr\/\">Indapamid\u0103<\/a>, metolazon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HTN (v\u00e2rstnici, dovezi HYVET), blocaj secven\u021bial al nefronului<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Diuretic de ans\u0103 (scurt)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/lasix\/\">Furosemid\u0103<\/a>, bumetanid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Edem pulmonar acut, ICC, ascit\u0103, hipercalcemie<\/td>\n<\/tr>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Bucl\u0103 (lung\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/dytor\/\">Torasemid\u0103<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">IC cronic\u0103, HTA (singura bucl\u0103 cu dovezi pentru HTA), edem la BCR<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antagonist de aldosteron\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Spironolacton\u0103<\/a>, eplerenon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">IC-FER (RALES), HTA rezistent\u0103 (PATHWAY-2), sindrom Conn, ascit\u0103 cirotic\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Alte economizoare de potasiu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Amilorid\u0103, triamteren (de obicei \u00een combina\u021bii)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevenirea hipokaliemiei atunci c\u00e2nd se adaug\u0103 la bucl\u0103\/tiazidic\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Anhidraz\u0103 carbonic\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Acetazolamid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mal de altitudine, glaucom, alcaloz\u0103 metabolic\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Dytor la temperaturi sub 25\u00b0C \u00een ambalajul original blister. Depozita\u021bi \u00een afara accesului copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 iau Dytor \u2014 diminea\u021ba sau seara?<\/h3>\n<p><strong>Diminea\u021ba<\/strong> \u00een aproape toate cazurile. Efectul diuretic produce o cre\u0219tere a produc\u021biei de urin\u0103 timp de 2-4 ore dup\u0103 administrare. Administrarea seara provoac\u0103 nocturie \u0219i perturb\u0103 somnul. Pacien\u021bii care iau diuretice de ans\u0103 de dou\u0103 ori pe zi le administreaz\u0103 de obicei la micul dejun \u0219i la pr\u00e2nz (nu la culcare).<\/p>\n<h3 class=\"wp-block-heading\">Este Dytor un medicament de prim\u0103 linie pentru hipertensiune?<\/h3>\n<p><strong>Nu.<\/strong> Diureticele de ans\u0103 sunt <strong>nu sunt antihipertensive de prim\u0103 linie<\/strong> \u2014 ac\u021bioneaz\u0103 prea scurt \u0219i produc varia\u021bii ale tensiunii arteriale. Diureticele de ans\u0103 sunt utilizate pentru hipertensiune doar \u00een situa\u021bii specifice: edem \u00een insuficien\u021b\u0103 cardiac\u0103 concomitent\u0103, boal\u0103 renal\u0103 cronic\u0103 avansat\u0103 (eGFR &lt;30) c\u00e2nd tiazidele e\u0219ueaz\u0103 sau hipertensiune rezistent\u0103 ca tratament adjunct. Pentru hipertensiunea standard, alege\u021bi o tiazid\u0103, un ARB, un inhibitor ACE sau un blocant al canalelor de calciu.<\/p>\n<h3 class=\"wp-block-heading\">Va afecta Dytor nivelul meu de potasiu?<\/h3>\n<p>Da \u2014 Dytor <strong>scade<\/strong> potasiul prin cre\u0219terea excre\u021biei de potasiu la nivelul tubului distal. Monitoriza\u021bi la ini\u021biere, dup\u0103 1-2 s\u0103pt\u0103m\u00e2ni \u0219i periodic. Riscul de hipokaliemie este <strong>minimizat prin combinarea<\/strong> Dytor cu un ARB sau inhibitor ACE \u2014 care este combina\u021bia standard \u00een hipertensiune. Dac\u0103 potasiul scade sub 3.5 \u00een cazul utiliz\u0103rii izolate a diureticului, ad\u0103uga\u021bi suplimente de potasiu, o diet\u0103 bogat\u0103 \u00een potasiu sau o doz\u0103 mic\u0103 de un agent care p\u0103streaz\u0103 potasiul (spironolacton\u0103, eplerenon\u0103 sau un <a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">amilorid\u0103<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Am gut\u0103 \u2014 pot lua Dytor?<\/h3>\n<p>Cu precau\u021bie. Diureticele tiazidice \u0219i (\u00een mai mic\u0103 m\u0103sur\u0103) cele de tip bucl\u0103 cresc acidul uric seric prin competi\u021bia pentru excre\u021bia la nivelul tubului proximal. La pacien\u021bii predispu\u0219i la gut\u0103: prefera\u021bi combina\u021biile pe baz\u0103 de losartan (<a href=\"https:\/\/medsbase.com\/ro\/cosart-h\/\">Cosart H<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/cozartan-h\/\">Cozartan H<\/a>) al c\u0103rui component losartan este unic uricosuric \u0219i contracareaz\u0103 cre\u0219terea de urat cauzat\u0103 de tiazide. Dac\u0103 Dytor este deja utilizat \u0219i apar accese de gut\u0103, ad\u0103uga\u021bi sau continua\u021bi terapia de reducere a uratului (alopurinol) \u00een loc s\u0103 \u00eentrerupe\u021bi brusc Dytor.<\/p>\n<h3 class=\"wp-block-heading\">Sunt diabetic \u2014 este Dytor sigur?<\/h3>\n<p>\u00cen mare parte da, dar fi\u021bi con\u0219tient c\u0103 tiazidele \u0219i (\u00eentr-o m\u0103sur\u0103 mai mic\u0103) diureticele de ans\u0103 <strong>\u00eenr\u0103ut\u0103\u021besc modest toleran\u021ba la glucoz\u0103<\/strong> (cre\u0219tere medie a glicemiei \u00een post 5-8 mg\/dL, HbA1c 0,1-0,3%). Beneficiul asupra tensiunii arteriale dep\u0103\u0219e\u0219te acest efect la majoritatea diabeticilor. Dac\u0103 dori\u021bi o combina\u021bie metabolic mai neutr\u0103, ARB+CCB este o alternativ\u0103 (<a href=\"https:\/\/medsbase.com\/ro\/olmezest-am\/\">Olmezest AM<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Pot lua ibuprofen cu Dytor?<\/h3>\n<p>Utilizarea ocazional\u0103 pe termen scurt este de obicei \u00een regul\u0103. NSAID-urile utilizate zilnic pe termen lung (ibuprofen, diclofenac, naproxen) <strong>reduc efectul diuretic \u0219i antihipertensiv<\/strong> a Dytor (blocarea prostaglandinelor) \u0219i cresc substan\u021bial riscul de leziune renal\u0103 acut\u0103 atunci c\u00e2nd sunt combinate cu un inhibitor ACE sau ARB \u2014 \u201ctriplul impact\u201d. Utiliza\u021bi paracetamol preferen\u021bial pentru durerea cronic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Voi urina mai mult noaptea?<\/h3>\n<p>De obicei nu, dac\u0103 lua\u021bi Dytor diminea\u021ba. Efectul diuretic atinge maximul la 2-4 ore dup\u0103 administrare \u0219i se diminueaz\u0103 \u00een mare parte p\u00e2n\u0103 seara. Nocturia este o pl\u00e2ngere frecvent\u0103 c\u00e2nd pacien\u021bii trec la administrarea seara; reveni\u021bi la administrarea diminea\u021ba \u0219i nocturia se rezolv\u0103 \u00een 1-3 zile.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Dytor \u00een timpul sarcinii?<\/h3>\n<p>Evitat \u00een mod obi\u0219nuit. Diureticele de ans\u0103 trec prin placent\u0103 \u0219i pot afecta f\u0103tul. Pentru hipertensiunea \u00een sarcin\u0103, trece\u021bi la <a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">labetalol<\/a>, metildopa sau nifedipin\u0103. Diureticele sunt utilizate \u00een sarcin\u0103 doar pentru indica\u021bii specifice (edem pulmonar, insuficien\u021b\u0103 cardiac\u0103 rezistent\u0103) sub supraveghere specializat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi-l c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi, cu excep\u021bia cazului \u00een care este aproape timpul pentru urm\u0103toarea doz\u0103 \u2014 \u00een acest caz omite\u021bi doza ratat\u0103. Nu dubla\u021bi doza. O singur\u0103 doz\u0103 ratat\u0103 nu afecteaz\u0103 semnificativ controlul tensiunii arteriale pe termen lung sau al fluidelor.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Dytor online?<\/h3>\n<p>Pute\u021bi achizi\u021biona Dytor (5 \/ 10 \/ 20 mg torasemid\u0103, 30-180 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Antihipertensive \u0219i Diuretice Asem\u0103n\u0103toare pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">Amifru \u2014 Furosemid\u0103 + Amilorid\u0103 (diuretic de ans\u0103 + economisitor de potasiu)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cosart-h\/\">Cosart H \u2014 Losartan + HCTZ combina\u021bie fix\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/losar\/\">Losar \u2014 Losartan (ARB asociat cu diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/natrilix-sr\/\">Natrilix SR \u2014 Indapamid\u0103 1,5 mg SR (asem\u0103n\u0103tor tiazidelor)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ramcor\/\">Ramcor \u2014 Ramipril (partener ACEi pentru diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/telmaheal\/\">Telmaheal \u2014 Telmisartan (partener ARB pentru diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui medic calificat. Hipertensiunea, insuficien\u021ba cardiac\u0103 \u0219i aritmiile necesit\u0103 diagnostic, monitorizare \u0219i individualizarea dozei de c\u0103tre un medic \u2014 utiliza\u021bi \u00eentotdeauna beta-blocante sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/voritrol\/\">Voritrol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glynase-mf\/\">Glynase-MF<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/arkamin-h\/\">Arkamin-H<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/fluvoxin\/\">Fluvoxin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hydrosar\/\">Hydrosar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Dytor este comprimatul de torasemid\u0103 5\/10\/20 mg al lui Cipla \u2014 diuretic de ans\u0103 cu ac\u021biune prelungit\u0103 \u0219i biodisponibilitate previzibil\u0103 de 80-100% (fa\u021b\u0103 de furosemid\u0103 10-90%). Preferat la pacien\u021bii cu edem intestinal, r\u0103spuns inconsistent la furosemid\u0103 sau care necesit\u0103 acoperire diuretic\u0103 de ans\u0103 o dat\u0103 pe zi. Antagonismul u\u0219or al aldosteronului reduce hipokaliemia. Singurul diuretic de ans\u0103 cu dovezi rezonabile \u00een hipertensiune. TRANSFORM-HF 2023 \u2014 mortalitate echivalent\u0103 cu furosemida \u00een insuficien\u021ba cardiac\u0103.<\/p>","protected":false},"featured_media":0,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[4941,4942],"class_list":{"0":"post-60882","1":"product","2":"type-product","3":"status-publish","5":"product_cat-category-overview","6":"product_cat-chronic-conditions","7":"product_cat-heart-blood-pressure","8":"product_cat-high-blood-pressure-medication","9":"product_tag-dytor","10":"product_tag-torasemide","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/60882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=60882"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=60882"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=60882"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=60882"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=60882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}